Study Finds Cancer Drug May Also Flush Out Dormant HIV

It pushes HIV out of hiding. 🤔 engineering

Part of the reason HIV is so hard to cure is that it

“It’s not straightforward to bring this approach to the clinic in people living with HIV without cancer,” explained “The side effects of immunotherapy currently are significant, for example, five to 10 percent of people will get an adverse event. In a cancer setting, this isn’t a major concern as you have a life-threatening illness, but in HIV, the situation is very different. People can now live normal and healthy lives with HIV, so any intervention for a cure must have very low toxicity.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

IntEngineering /  🏆 287. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

‘Shocking' Study Finds Employees Went to Work Sick Because of Pressure from Management, No Sick PayThere’s an alarming trend, researchers have found among service workers: going to work sick during the pandemic. Many are feeling the pressure to show up as companies are understaffed
Les mer »

Moderna begins human trials for HIV vaccineModerna has launched early-stage human trials for an mRNA vaccine to treat HIV, the company announced to investors on Thursday.
Les mer »

Moderna Launches Clinical Trials for HIV VaccineHuman clinical trials have started for an experimental HIV vaccine that uses the same kind of mRNA technology found in Moderna’s successful COVID-19 vaccine, the drug company announced this week.
Les mer »

Moderna launches clinical trial for HIV vaccine that uses mRNA technologyModerna announced Thursday that it's launched early-stage clinical trials of an HIV mRNA vaccine. The biotechnology company has teamed up with the nonprofit ​​International AIDS Vaccine Initiative to develop the shot, which uses the same technology as Moderna's successful COVID-19 vaccine. The first participants in the Phase I trial were given doses at George Washington University School of Medicine and Health Sciences in Washington, D.C., according to a company statement.
Les mer »

Moderna’s mRNA HIV Vaccine Begins Early-Stage Human TrialsModerna has begun clinical trials of its HIV vaccine that employs messenger RNA, much like the company's successful COVID-19 vaccine.
Les mer »

Moderna launches clinical trial for HIV vaccine that uses mRNA technology
Les mer »